Albumin administration in patients with cirrhosis: Current role and novel perspectives

Alliance of Brazilian Centers for Cirrhosis Care – the ABC Group

Research output: Contribution to journalReview articlepeer-review


Mortality in cirrhosis is mostly associated with the development of clinical decompensation, characterized by ascites, hepatic encephalopathy, variceal bleeding, or jaundice. Therefore, it is important to prevent and manage such complications. Traditionally, the pathophysiology of decompensated cirrhosis was explained by the peripheral arterial vasodilation hypothesis, but it is currently understood that decompensation might also be driven by a systemic inflammatory state (the systemic inflammation hypothesis). Considering its oncotic and nononcotic properties, albumin has been thoroughly evaluated in the prevention and management of several of these decompensating events. There are formal evidence-based recommendations from international medical societies proposing that albumin be administered in individuals with cirrhosis undergoing large-volume paracentesis, patients with spontaneous bacterial peritonitis, those with acute kidney injury (even before the etiological diagnosis), and those with hepatorenal syndrome. Moreover, there are a few randomized controlled trials and meta-analyses suggesting a possible role for albumin infusion in patients with cirrhosis and ascites (long-term albumin administration), individuals with hepatic encephalopathy, and those with acute-on-chronic liver failure undergoing modest-volume paracentesis. Further studies are necessary to elucidate whether albumin administration also benefits patients with cirrhosis and other complications, such as individuals with extraperitoneal infections, those hospitalized with decompensated cirrhosis and hypoalbuminemia, and patients with hyponatremia.

Original languageEnglish (US)
Pages (from-to)4773-4786
Number of pages14
JournalWorld journal of gastroenterology
Issue number33
StatePublished - Sep 7 2022


  • Acute kidney injury
  • Albumin
  • Cirrhosis
  • Hepatorenal syndrome
  • Paracentesis
  • Spontaneous bacterial peritonitis

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Albumin administration in patients with cirrhosis: Current role and novel perspectives'. Together they form a unique fingerprint.

Cite this